Elsevier

Biochemical Pharmacology

Volume 52, Issue 2, 26 July 1996, Pages 273-280
Biochemical Pharmacology

Research paper
Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone

https://doi.org/10.1016/0006-2952(96)00204-3Get rights and content

Abstract

The mechanism of the anti-anginal effect of perhexiline is unclear but appears to involve a shift in cardiac metabolism from utilization of fatty acid to that of carbohydrate. We tested the hypothesis that perhexiline inhibits the enzyme carnitine palmitoyltransferase-1 (CPT-1), which controls access of long chain fatty acids to the mitochondrial site of β-oxidation. Perhexiline produced a concentration-dependent inhibition of CPT-1 in rat cardiac and hepatic mitochondria in vitro, with half-maximal inhibition (ic50) at 77 and 148 μmol/L, respectively. Amiodarone, another drug with anti-anginal properties, also inhibited cardiac CPT-1 (ic50 = 228 μmol/L). The rank order of potency for inhibition was malonyl-CoA > 4-hydroxyphenylglyoxylate (HPG) = perhexiline > amiodarone = monohydroxy-perhexiline. Kinetic analysis revealed competitive inhibition of cardiac and hepatic CPT-1 by perhexiline with respect to palmitoyl-CoA but non-competitive inhibition with respect to carnitine. Curvilinear Dixon plots generated “apparent inhibitory constant (Ki)” values for perhexiline, which indicated a greater sensitivity of the cardiac than the hepatic enzyme to inhibition by perhexiline. Perhexiline inhibition of CPT-1, unlike that of malonyl-CoA and HPG, was unaffected by pretreatment with the protease nagarse. These data establish for the first time that two agents with proven anti-anginal effects inhibit cardiac CPT-1. This action is likely to contribute to the anti-ischaemic effects of both perhexiline and amiodarone.

References (39)

  • K Kashfi et al.

    Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidation

    Biochim Biophys Acta

    (1994)
  • JB McMillin et al.

    Evidence for malonyl-CoA-sensitive carnitine acyl-CoA transferase activity in sarcoplasmic reticulum of canine heart

    J Mol Cell Cardiol

    (1992)
  • BC Weis et al.

    Rat heart expresses two forms of mitochondrial carnitine palmitoyltransferase I

    J Biol Chem

    (1994)
  • GA Cook

    Differences in sensitivity of carnitine palmitoyltransferase to inhibition by malonyl-CoA are due to differences in Ki values

    J Biol Chem

    (1984)
  • AJ Higgins et al.

    Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischaemic rat heart

    Life Sci

    (1980)
  • PL Cole et al.

    Efficacy and safety of perhexiline maleate in refractory angina

    Circulation

    (1990)
  • WH Barry et al.

    Comparison of negative inotropic potency, reversibility, and effects of calcium influx of six calcium channel antagonists in cultured myocardial cells

    Br J Pharmacol

    (1985)
  • CJ Pepine et al.

    Alteration of left ventricular responses to ischemia with oral perhexiline

    Postgrad Med J

    (1973)
  • CJ Pepine et al.

    Effects of perhexiline on coronary hemodynamic and myocardial metabolic responses to tachycardia

    Circulation

    (1974)
  • Cited by (0)

    View full text